HIGHLIGHTS
- who: User from the Department of DiBEST (Biologia, Ecologia, Scienze della Terra) Unit of Biochemistry and MolecularBiotechnology, via Bucci C, University of Calabria, Arcavacata di Rende, Italy have published the paper: Current Research in Discovery (1): 1-16 3.0 IN DISCOVERY, in the Journal: (JOURNAL)
- what: The identification of important for absorption and side effect production and the best technologies for studying interactions are the main goals in this field. are not yet considered in human therapy in spite of their involvement in several pathologies. Noteworthy, for those pathological conditions characterized by increased glutamaergic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.